DK0501656T3 - Benzenderivater med en fremskyndende aktivitet på produktion af nervevækstfaktor - Google Patents
Benzenderivater med en fremskyndende aktivitet på produktion af nervevækstfaktorInfo
- Publication number
- DK0501656T3 DK0501656T3 DK92301326.2T DK92301326T DK0501656T3 DK 0501656 T3 DK0501656 T3 DK 0501656T3 DK 92301326 T DK92301326 T DK 92301326T DK 0501656 T3 DK0501656 T3 DK 0501656T3
- Authority
- DK
- Denmark
- Prior art keywords
- group
- amino group
- substituted
- growth factor
- nerve growth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2706091 | 1991-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0501656T3 true DK0501656T3 (da) | 1997-07-21 |
Family
ID=12210527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92301326.2T DK0501656T3 (da) | 1991-02-21 | 1992-02-18 | Benzenderivater med en fremskyndende aktivitet på produktion af nervevækstfaktor |
Country Status (16)
Country | Link |
---|---|
US (2) | US5643925A (da) |
EP (1) | EP0501656B1 (da) |
JP (1) | JPH05112515A (da) |
KR (1) | KR920016406A (da) |
CN (1) | CN1036064C (da) |
AT (1) | ATE148098T1 (da) |
CA (1) | CA2061557A1 (da) |
CZ (1) | CZ50092A3 (da) |
DE (1) | DE69216873T2 (da) |
DK (1) | DK0501656T3 (da) |
ES (1) | ES2099206T3 (da) |
GR (1) | GR3022594T3 (da) |
HK (1) | HK1005722A1 (da) |
HU (1) | HUT64012A (da) |
IE (1) | IE920538A1 (da) |
RU (1) | RU2042663C1 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5993856A (en) * | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
GB2349880A (en) | 1999-05-10 | 2000-11-15 | Secr Defence | (Thio)morpholinium salts having SHG activity |
US6348648B1 (en) | 1999-11-23 | 2002-02-19 | Harry Connick, Jr. | System and method for coordinating music display among players in an orchestra |
US20030203857A1 (en) * | 2000-04-11 | 2003-10-30 | Hiromu Ohnogi | Remedies |
DE10115994A1 (de) * | 2001-03-30 | 2002-10-10 | Wella Ag | (p-Amino-hydroxyphenyl)acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel |
CA2468544A1 (en) * | 2001-12-10 | 2003-06-19 | Amgen Inc. | Vanilloid receptor ligands |
KR100459917B1 (ko) * | 2001-12-14 | 2004-12-03 | (주)바이오뉴트리젠 | 페놀릭산 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물 |
GB0312609D0 (en) | 2003-06-02 | 2003-07-09 | Astrazeneca Ab | Novel compounds |
SE0302139D0 (sv) * | 2003-07-28 | 2003-07-28 | Astrazeneca Ab | Novel compounds |
JP2006008642A (ja) * | 2004-06-29 | 2006-01-12 | Sumitomo Bakelite Co Ltd | アミノフェノール化合物、熱硬化性化合物およびその製造法 |
US7652041B2 (en) * | 2005-01-14 | 2010-01-26 | Millennium Pharmaceuticals, Inc. | Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity |
US8637706B2 (en) | 2005-11-28 | 2014-01-28 | Gtx, Inc. | Nuclear receptor binding agents |
US8546451B2 (en) | 2005-11-28 | 2013-10-01 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
US9409856B2 (en) | 2005-11-28 | 2016-08-09 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
US8158828B2 (en) | 2005-11-28 | 2012-04-17 | Gtx, Inc. | Nuclear receptor binding agents |
EP2139879B1 (en) * | 2007-03-22 | 2012-07-11 | AstraZeneca AB | Quinoline derivatives for the treatment of inflammatory diseases |
PE20091036A1 (es) | 2007-11-30 | 2009-08-15 | Astrazeneca Ab | Derivado de quinolina como antagonista del receptor p2x7 |
US9624161B2 (en) | 2009-02-23 | 2017-04-18 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
US9427418B2 (en) | 2009-02-23 | 2016-08-30 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3147261A (en) * | 1962-05-24 | 1964-09-01 | Robert R Mod | Nu-acyl-nu'-methylpiperazines |
GB1052308A (da) * | 1964-08-25 | |||
GB8417194D0 (en) * | 1984-07-05 | 1984-08-08 | Boots Co Plc | Therapeutic agents |
NZ228329A (en) * | 1988-03-18 | 1991-12-23 | Mitsui Toatsu Chemicals | Catechol derivatives and pharmaceutical compositions thereof |
JPH02104568A (ja) * | 1988-06-22 | 1990-04-17 | Yoshitomi Pharmaceut Ind Ltd | 神経成長因子産生促進作用剤 |
PT94121A (pt) * | 1989-05-23 | 1991-02-08 | Sankyo Co | Processo para a preparacao de derivados fenol para promover o factor de crescimento do nervo humano |
JP2761048B2 (ja) * | 1989-08-25 | 1998-06-04 | 三共株式会社 | 神経成長因子産生促進剤 |
-
1992
- 1992-02-18 US US07/837,491 patent/US5643925A/en not_active Expired - Fee Related
- 1992-02-18 DE DE69216873T patent/DE69216873T2/de not_active Expired - Fee Related
- 1992-02-18 ES ES92301326T patent/ES2099206T3/es not_active Expired - Lifetime
- 1992-02-18 EP EP92301326A patent/EP0501656B1/en not_active Expired - Lifetime
- 1992-02-18 AT AT92301326T patent/ATE148098T1/de active
- 1992-02-18 DK DK92301326.2T patent/DK0501656T3/da active
- 1992-02-20 RU SU925011163A patent/RU2042663C1/ru active
- 1992-02-20 IE IE053892A patent/IE920538A1/en not_active Application Discontinuation
- 1992-02-20 CZ CS92500A patent/CZ50092A3/cs unknown
- 1992-02-20 CA CA002061557A patent/CA2061557A1/en not_active Abandoned
- 1992-02-21 KR KR1019920002675A patent/KR920016406A/ko not_active Application Discontinuation
- 1992-02-21 HU HU9200579A patent/HUT64012A/hu unknown
- 1992-02-21 CN CN92101074A patent/CN1036064C/zh not_active Expired - Fee Related
- 1992-02-21 JP JP4035254A patent/JPH05112515A/ja active Pending
-
1995
- 1995-04-24 US US08/427,664 patent/US5614521A/en not_active Expired - Fee Related
-
1997
- 1997-02-19 GR GR970400279T patent/GR3022594T3/el unknown
-
1998
- 1998-06-03 HK HK98104826A patent/HK1005722A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GR3022594T3 (en) | 1997-05-31 |
EP0501656B1 (en) | 1997-01-22 |
ES2099206T3 (es) | 1997-05-16 |
DE69216873T2 (de) | 1997-08-21 |
RU2042663C1 (ru) | 1995-08-27 |
KR920016406A (ko) | 1992-09-24 |
HU9200579D0 (en) | 1992-05-28 |
EP0501656A3 (en) | 1993-03-03 |
JPH05112515A (ja) | 1993-05-07 |
CZ50092A3 (en) | 1993-03-17 |
ATE148098T1 (de) | 1997-02-15 |
CN1064273A (zh) | 1992-09-09 |
US5614521A (en) | 1997-03-25 |
CA2061557A1 (en) | 1992-08-22 |
IE920538A1 (en) | 1992-08-26 |
CN1036064C (zh) | 1997-10-08 |
HUT64012A (en) | 1993-11-29 |
HK1005722A1 (en) | 1999-01-22 |
US5643925A (en) | 1997-07-01 |
DE69216873D1 (de) | 1997-03-06 |
EP0501656A2 (en) | 1992-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0501656T3 (da) | Benzenderivater med en fremskyndende aktivitet på produktion af nervevækstfaktor | |
DE69026980D1 (de) | Schwefel enthaltende kondensierte Pyrimidinderivate, ihre Herstellung und Verwendung | |
AU8249391A (en) | Sulfonamide derivatives | |
IL100788A0 (en) | Benzamides | |
NO931529L (no) | Cykliske fruktopyranosesulfitter og -sulfater med antikonvulsiv effekt | |
EP0976732A4 (en) | 1,4-SUBSTITUTED CYCLIC AMINE DERIVATIVES | |
AU1639888A (en) | Novel oxetanocins | |
DE69428142D1 (de) | Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung | |
IL94027A0 (en) | Diaminoethylene compounds | |
MX9206093A (es) | Derivado de oxazolidona | |
ES8604604A1 (es) | Un procedimiento para la produccion de 3,3",4"-tri-o-acilespiramicina i"-. | |
ATE80613T1 (de) | Verwendung von spergualinderivaten zur herstellung von arzneimitteln mit immunodepressiver wirkung. | |
PT89098A (pt) | Processo para a preparacao de derivados de guanina | |
SE8701904D0 (sv) | Organiska foreningar | |
AU8003594A (en) | Quinolinecarboxylic acid derivative and salt thereof | |
MY104689A (en) | Amine salts of 1,4,2-oxazaphospholidine-4-acetic acid, 2-alkoxy-2-oxides. | |
AU7453487A (en) | Cis and trans stilbenes |